BR100 Increased By (2.8%)
BR30 Increased By (3.57%)
KSE100 Increased By (2.38%)
KSE30 Increased By (2.44%)
AGHA 6.12 Increased By ▲ 0.09 (1.49%)
BECO 4.16 Increased By ▲ 0.30 (7.77%)
BML 62.73 Increased By ▲ 1.73 (2.84%)
BOP 30.90 Increased By ▲ 2.81 (10%)
CNERGY 11.97 Increased By ▲ 0.23 (1.96%)
CSIL 5.42 Increased By ▲ 0.12 (2.26%)
FCCL 56.78 Increased By ▲ 2.32 (4.26%)
FFL 13.34 Increased By ▲ 0.27 (2.07%)
FNEL 1.15 Increased By ▲ 0.04 (3.6%)
KEL 6.00 Increased By ▲ 0.37 (6.57%)
KOSM 5.48 Increased By ▲ 0.14 (2.62%)
LOTCHEM 24.37 Increased By ▲ 0.54 (2.27%)
MLCF 97.49 Increased By ▲ 4.51 (4.85%)
NBP 174.50 Increased By ▲ 11.30 (6.92%)
NCPL 48.47 Increased By ▲ 0.20 (0.41%)
NPL 50.23 Increased By ▲ 0.52 (1.05%)
OGDC 310.47 Increased By ▲ 6.84 (2.25%)
PACE 9.05 Increased By ▲ 0.08 (0.89%)
PAEL 33.07 Increased By ▲ 1.16 (3.64%)
PIBTL 13.15 Increased By ▲ 0.41 (3.22%)
PPL 217.17 Increased By ▲ 4.26 (2%)
PRL 85.66 Increased By ▲ 1.32 (1.57%)
PTC 46.19 Increased By ▲ 1.20 (2.67%)
SSGC 23.32 Increased By ▲ 0.49 (2.15%)
TBL 9.02 Increased By ▲ 0.14 (1.58%)
TELE 6.73 Increased By ▲ 0.23 (3.54%)
TPL 26.10 Increased By ▲ 1.84 (7.58%)
TPLP 12.67 Increased By ▲ 0.68 (5.67%)
TREET 23.80 Increased By ▲ 0.66 (2.85%)
TRG 53.17 Increased By ▲ 1.70 (3.3%)
Pakistan

PM Shehbaz hails $440mn Pakistan-China pharma deals, says partnership to advance CPEC 2.0

  • Security of Chinese nationals working in Pakistan remains govt's top priority, premier says
Published Updated
ISLAMABAD: Prime Minister Muhammad Shehbaz Sharif witnesses the signing and exchange of agreements between Chinese and Pakistani pharmaceutical companies at the Pak China Pharmaceutical B2B Conference on 17 July 2026. - Photo: PMO
ISLAMABAD: Prime Minister Muhammad Shehbaz Sharif witnesses the signing and exchange of agreements between Chinese and Pakistani pharmaceutical companies at the Pak China Pharmaceutical B2B Conference on 17 July 2026. - Photo: PMO
By

Prime Minister Shehbaz Sharif on Friday hailed the signing of nine agreements worth around $440 million between Pakistani and Chinese private enterprises in the pharmaceutical sector, describing the development as a major step towards strengthening bilateral economic cooperation and advancing the next phase of the China-Pakistan Economic Corridor (CPEC 2.0).

Addressing the Pakistan-China Pharmaceutical Business-to-Business Conference in Islamabad, the prime minister expressed confidence that the agreements would turn into practical projects, saying they would boost investment in pharmaceutical manufacturing, vaccines, research and development, and help Pakistan emerge as a regional centre for the production and export of life-saving medicines.

“I think this will ultimately result into manufacturing life saving medicines, vaccines, research and development and become a center of excellence for exporting our wonderful products to neighboring countries,” he said.

He said China had consistently stood by Pakistan during difficult times and had already invested more than $30 billion under first phase of CPEC, calling the new partnerships another milestone in expanding economic cooperation.

The prime minister also highlighted Pakistan’s role in promoting regional peace, saying Islamabad had played an important mediating role during the recent regional crisis with the support of friendly countries, particularly China.

He appreciated the contributions of President Xi Jinping, Premier Li Qiang and other Chinese leaders, while also acknowledged the efforts of Field Marshal, Syed Asim Munir, and Deputy Prime Minister, Ishaq Dar in diplomatic engagements.

Reaffirming Pakistan’s commitment to Chinese investors, he said the security of Chinese nationals working in Pakistan remained the government’s highest priority and assured them of comprehensive protection.

Chinese Ambassador Jiang Zaidong said Pakistan’s large and growing population had created significant demand for healthcare, making the country’s pharmaceutical sector an attractive destination for investment and cooperation. He said the embassy had worked as a bridge between enterprises of both countries to promote business partnerships.

Comments

200 characters remaining